Portfolio Realized

Company: Vernalis - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Vernalis is a development-stage pharmaceutical company listed on the London Stock Exchange.

Company: Omrix - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

OMRIX biopharmaceuticals is a marketing stage biotechnology company that develops and markets a unique surgical sealant, as well as a suite of immunology and hemophilia products. The company was initially listed on NASDAQ and subsequently acquired by J&J.

Company: Intercell - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Intercell is a biotechnology company focused on the development of vaccines against infectious diseases and cancer, initially listed on the Vienna Stock Exchange, and subsequently merged into Valneva.

Company: Ingenium - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Ingenium Pharmaceuticals is a drug discovery and development company focused on generating the biological information critical to the development of therapeutics, specifically in the area of pain management and inflammatory disease. The company was acquired by ProBiodrug AG.

Company: Galapagos - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Galapagos is a biotechnology company focused on the identification of disease modifying drug targets and the subsequent development of breakthrough medicine based on these targets. The company is listed on Euronext.

Company: Epicept - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

EpiCept Corporation is a specialty niche pharmaceutical company. Epicept’s objective is to address unmet medical needs in cancer and pain management. The company is listed on the OTCQX and Stockholm Stock Exchange.

Company: Enanta - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best-in-class small molecule drugs in the anti-infectives field. The company is listed on the NASDAQ.

Company: DrugAbuse Sciences - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

DrugAbuse Sciences was a specialty pharmaceutical company dedicated to improving the treatment of alcohol and substance abuse and dependence. The company assets have been acquired by Elbion (now part of Biotie).

Company: Develogen - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

DeveloGen is a biology driven specialty pharmaceutical company focusing on the development of treatments for metabolic disorders, such as diabetes, obesity and metabolic syndrome. The company was acquired by Evotec.

Company: Curacyte - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Curacyte is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. The company was acquired by Wilex.

Company: Coley - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Coley Pharmaceutical Group discovers, develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancer, asthma, allergy and infectious diseases. The company was initially listed on NASDAQ and subsequently acquired by Pfizer.

Company: Breonics - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Breonics, Inc. is a biomedical research and development company on the cutting edge of innovative medical products for the clinical organ transplant and tissue replacement markets.

Company: BioXell - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

BioXell was a research and development biopharmaceutical company with globally recognised leadership in Vitamin D and its in-depth understanding of the molecular basis of inflammation. The company was initially listed on the Swiss stock exchange and subsequently acquired by Cosmo Pharmaceuticals.

Company: Avantium B.V. - Visit website
Fund: AlpInvest Life Sciences
Year: Prior to 2008
Status: Realized

Avantium is a Dutch service and R&D company. Avantium provides innovative high-throughput R&D services and technologies to the pharmaceutical, chemical and energy industries. Our position was sold in a secondary transaction.

Company: Okapi Sciences N.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized

Okapi develops antiviral drug products to treat viral diseases in pet animals and livestock. The company was acquired by Aratana Therapeutics Inc.

Company: Bioceros B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized

Bioceros is active in the field of protein therapeutics, and offers producer cell line generation services; it also aims to develop an own therapeutic monoclonal antibody pipeline. Our position was sold to a strategic investor.